Viral Gastroenteritis Market Poised for Growth, Expected to Reach $8.1 Billion by 2028
Viral Gastroenteritis Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
The Business Research Company’s Viral Gastroenteritis Global Market Report 2024 – Market Size, Trends, And Global Forecast 2024-2033
LONDON, GREATER LONDON, UK, July 4, 2024 /EINPresswire.com/ -- The viral gastroenteritis market has shown robust growth in recent years, projected to increase from $6.34 billion in 2023 to $6.7 billion in 2024, with a compound annual growth rate (CAGR) of 5.7%. Factors contributing to this growth include the prevalence of viral infections, global hygiene practices, advancements in diagnostics, global travel and tourism, and climate and environmental factors.
Rising Prevalence of Gastrointestinal Disorders Drives Market Growth
The increasing prevalence of gastrointestinal disorders, including viral gastroenteritis, is a significant driver for market expansion. These disorders affect the gastrointestinal tract, leading to symptoms such as watery diarrhea, nausea, stomach cramps, and fever. A survey by Bodibio in October 2021 highlighted a high prevalence of functional gastrointestinal disorders globally, underscoring the need for effective treatments and diagnostics.
Explore the global viral gastroenteritis market with a detailed sample report:
https://www.thebusinessresearchcompany.com/sample_request?id=12127&type=smp
Key Players and Market Trends
Major companies driving innovation in the viral gastroenteritis market include Pfizer Inc., Abbvie Inc., Bayer AG, and Sanofi S.A. These companies are focusing on developing new products such as PCR kits for gastrointestinal infectious diseases. For example, Jiangsu Bioperfectus Technologies Co. Ltd. launched Real-Time PCR Kits for accurate detection of gastrointestinal pathogens, enhancing diagnostic capabilities in clinical settings.
Trends in the Forecast Period
Key trends shaping the viral gastroenteritis market include advancements in vaccine development, adoption of advanced diagnostics like telemedicine, collaborative research initiatives, personalized medicine approaches, and integration of digital health solutions. These trends aim to improve patient outcomes and enhance disease management strategies.
Viral Gastroenteritis Market Segments
The viral gastroenteritis market is segmented based on:
• Drugs: Antibiotics, Antacids, Laxatives, Antimotility Agents, Others Drugs
• Diagnosis: Physical Examination, Rapid Stool Test
• Indication: Watery Diarrhea, Abdominal Cramps, Pain, Other Indications
• Type Of Virus: Norovirus, Rotavirus, Astrovirus, Enteric Adenovirus
• End User: Hospitals, Clinics, Pharmaceutical Companies, Diagnostic Centers, Ambulatory Care Centers, Others End Users
Geographical Insights: Asia-Pacific Leading the Market
North America dominated the viral gastroenteritis market in 2023, while Asia-Pacific is expected to witness the fastest growth during the forecast period. Detailed regional dynamics and growth opportunities can be explored in the comprehensive market report.
Access the complete report for an in-depth analysis of the global viral gastroenteritis market: https://www.thebusinessresearchcompany.com/report/viral-gastroenteritis-global-market-report
Viral Gastroenteritis Global Market Report 2024 from TBRC covers the following information:
• Market size data for the forecast period: Historical and Future
• Market analysis by region: Asia-Pacific, China, Western Europe, Eastern Europe, North America, USA, South America, Middle East and Africa.
• Market analysis by countries: Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.
Trends, opportunities, strategies and so much more.
The Viral Gastroenteritis Global Market Report 2024 by The Business Research Company is the most comprehensive report that provides insights on viral gastroenteritis market size, viral gastroenteritis market drivers and trends, viral gastroenteritis market major players, competitors' revenues, market positioning, and market growth across geographies. The viral gastroenteritis market report helps you gain in-depth insights on opportunities and strategies. Companies can leverage the data in the report and tap into segments with the highest growth potential.
Browse Through More Similar Reports By The Business Research Company:
Listeria Monocytogenes Infections Treatment Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/listeria-monocytogenes-infections-treatment-global-market-report
Antivirals Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/antivirals-global-market-report
Viral Vectors And Plasmid DNA Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/viral-vectors-and-plasmid-dna-global-market-report
About The Business Research Company
The Business Research Company has published over 27 industries, spanning over 8000+ markets and 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.
Global Market Model – Market Intelligence Database
The Global Market Model, The Business Research Company’s flagship product, is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets that help its users assess supply-demand gaps.
Contact Information
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 8897263534
Americas: +1 315 623 0293
Oliver Guirdham
The Business Research Company
+44 20 7193 0708
info@tbrc.info
Visit us on social media:
Facebook
X
LinkedIn
EIN Presswire does not exercise editorial control over third-party content provided, uploaded, published, or distributed by users of EIN Presswire. We are a distributor, not a publisher, of 3rd party content. Such content may contain the views, opinions, statements, offers, and other material of the respective users, suppliers, participants, or authors.
